ArticleFrontiers in oncology2023

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis.

Elsa Curtit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.